Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > If TH1902 does not work, we are done..YES or NO?

<< Previous

Bullboard Posts

Next >>

Comment by Kd5513on Aug 08, 2022 3:14pm

128 Views

Post# 34879616

RE:If TH1902 does not work, we are done..YES or NO?

90k shares out!!!! Not waiting for the slow growth over 10+ year plan on tesm. and trog.

It's time for the Leadership and Board to prove they can do something on cancer, if not I would have to say as many others here that I ussually push back against they have done nothing but collect a paycheck off our backs.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec